“Big Pharma” fails to convince TGA of product efficacy

In April last year, pharmaceutical company Key-Sun Laboratories were unable to substantiate claims they had made in an advertisement for a cold & flu product to the Therapeutic Goods Administration’s Complains Resolution Panel, Australia’s consumer protection watchdog for therapeutic goods.

The product, “Oscilococinum” is a manufactured by Boiron – who themselves were the target of a million-dollar class-action lawsuit for the same product, which they settled for $5 million dollars.

The findings by the TGACRP outlined in this document noted that Key-Sun, the advertiser, presented two studies to the TGA in an attempt to demonstrate the product was effective in relieving “fever, chills, body aches, and pains” as part of a cold or flu.

The findings include:

The Panel was satisfied that this evidence was not of a type, range, or quality that could support representations made in advertisements directed to consumers. The Panel also noted that the advertiser had not provided evidence that the studies provided reflected the full balance of evidence available in relation to the advertised product.

Big Pharmaceutical companies such as KeySun need reassess just why they are in the market place; this a blatant financial exploitation of the ignorant and misinformed, and their actions only reinforce the false tenants of homeopathics to those who could very well die as a result.

Unsurprisingly, many cynical advocates of homeopathy don’t consider similar products to fall under the category of “conventional” medicine, but considered an alternative to medicine.

I’m inclined to agree – Homeopathy is not medicine.

Leave a Reply